Implant Sciences Ships Follow-On Order to Japan for Protection of Nuclear Power Plant
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has shipped its Quantum Sniffer™ QS-H150 handheld explosives trace detector for the protection of a nuclear power facility in Japan. This customer has repeatedly purchased explosive trace detectors from Implant Sciences due to its non-radioactive source. To date, the Company has sold over $1 million to Japan and has continued to experience success with nuclear power plants and police customers in the region.
“Japan is one of many countries around the world that have strict regulations on radioactive materials,” said Implant Sciences President and CEO, Glenn D. Bolduc. “Our Quantum Sniffer product line delivers all the advantages of Ion Mobility Spectrometry trace detection without the disadvantages of radioactive materials.”
About the Quantum Sniffer™ QS-H150 Handheld Explosives Trace Detector
The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company’s QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

